Optimizing the Value of Real-World Evidence Projects

Pharmaceutical Executive September 13, 2021 Mark Davies and Paul Riley describe their a blueprint for exploring how healthcare companies can leverage real world evidence to access and engage customers more effectively. The not-so-simple challenge of brands and real-world evidence Real-world evidence (RWE) is defined as “the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of real-world data,” with real world data being “the data relating to patient health status and/or delivery of healthcare routinely collected from a variety of sources, including product and disease registries, patient-generated data including in home …

Read the source article at RamaOnHealthcare
2021-09-13 22:39:46